Zobrazeno 1 - 10
of 68
pro vyhledávání: '"Sheeba BA"'
Autor:
Charlotte B. Wagner, Ken Boucher, Adrienne Nedved, Ivana N. Micallef, Sanjal Desai, Haris Hatic, Gaurav Goyal, Erin Zacholski, Amanda Fegley, Audrey M. Sigmund, David A. Bond, Courtney Samuels, Manali K. Kamdar, Sheeba Ba Aqeel, Pallawi Torka, Kira MacDougall, Azra Borogovac, Sridevi Rajeeve, Suchitra Sundaram, Kalub Fedak, Dipenkumar Modi, Elizabeth Travers, Sabarish Ayyappan, Nitin Chilakamarri, Elizabeth A. Brem, Daniel A. Ermann, Lindsey A. Fitzgerald, Boyu Hu, Deborah M. Stephens, Harsh Shah
Publikováno v:
Haematologica, Vol 108, Iss 11 (2023)
Sixteen cycles of Brentuximab vedotin (BV) after autologous stem cell transplant (ASCT) in high-risk relapsed/refractory classical Hodgkin lymphoma demonstrated an improved 2-year progression-free survival (PFS) over placebo. However, most patients a
Externí odkaz:
https://doaj.org/article/551d8a1644b244c18b60306f73172409
Autor:
Harsh Shah, Victoria Vardell, Erin Zacholski, Amanda Fegley, Kalub Fedak, Suchitra Sundaram, Sridevi Rajeeve, Gaurav Goyal, Haris Hatic, Pallawi Torka, Sheeba Ba Aqeel, Azra Borogovac, Kira Macdougall, Shalin Kothari, Anna Kress, Dipenkumar Modi, Elizabeth Travers, Nitin Chilakamarri, Elizabeth Brem, Deborah M. Stephens, Boyu Hu, Lindsey Fitzgerlad, Charlotte Wagner, Daniel Ermann
Publikováno v:
HemaSphere, Vol 6, Pp 47-48 (2022)
Externí odkaz:
https://doaj.org/article/12d2af81c3be476aa4cbc5e716cec24c
Autor:
Sheeba Ba Aqeel, Minghao Ye, Jan Wysocki, Alejandro Sanchez, Ahmed Khattab, Enrique Lores, Alfred Rademaker, Xiaoyu Gao, Ionut Bebu, Robert G. Nelson, Mark Molitch, Daniel Batlle, For the Diabetes Control, Complications Trial (DCCT)/Epidemiology of Diabetes Interventions, Complications (EDIC) Study
Publikováno v:
Physiological Reports, Vol 7, Iss 19, Pp n/a-n/a (2019)
Abstract We examined if urinary angiotensinogen (uAOG), a marker of intrarenal renin‐angiotensin system activity, antedates stage 3 chronic kidney disease (CKD) using samples from participants in the Diabetes Control and Complications Trial (DCCT)
Externí odkaz:
https://doaj.org/article/3691b28e0c0d4b26a6ef3f164ade6e7b
Autor:
Akhtar, Othman Salim, Sheeba, Ba Aqeel, Azad, Farhan, Alessi, Lauren, Hansen, Doris, Alsina, Melissa, Baz, Rachid, Shain, Kenneth, Grajales Cruz, Ariel, Castaneda Puglianini, Omar, Liu, Hien, Blue, Brandon, Nishihori, Taiga, Al Jumayli, Mohammed, Extermann, Martine, Locke, Frederick L., Mhaskar, Rahul, Freeman, Ciara Louise
Publikováno v:
In Journal of Geriatric Oncology March 2024 15(2)
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Charlotte B. Wagner, Ken Boucher, Adrienne Nedved, Ivana N Micallef, Sanjal Desai, Haris Hatic, Gaurav Goyal, Erin Zacholski, Amanda Fegley, Audrey M. Sigmund, David A. Bond, Courtney Samuels, Manali K. Kamdar, Sheeba Ba Aqeel, Pallawi Torka, Kira MacDougall, Azra Borogovac, Sridevi Rajeeve, Suchitra Sundaram, Kalub Fedak, Dipenkumar Modi, Elizabeth Travers, Sabarish Ayyappan, Nitin Chilakamarri, Elizabeth A. Brem, Daniel A. Ermann, Lindsey A. Fitzgerald, Boyu Hu, Deborah M. Stephens, Harsh Shah
Publikováno v:
Haematologica.
Sixteen cycles of Brentuximab vedotin (BV) after autologous stem cell transplant (ASCT) in high-risk relapsed/refractory classical Hodgkin lymphoma (r/r cHL) demonstrated an improved 2-year progression free survival (PFS) over placebo. However, most
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f1b273bb1764670f7bc98462ac2828c0
https://doi.org/10.3324/haematol.2023.282780
https://doi.org/10.3324/haematol.2023.282780
Autor:
Charlotte B Wagner, Daniel A. Ermann, Ken Boucher, Adrienne N. Nedved, Ivana N. Micallef, Sanjal H Desai, Haris Hatic, Gaurav Goyal, Erin Zacholski, Amanda Fegley, Audrey M. Sigmund, David A. Bond, Courtney Samuels, Manali K. Kamdar, Sheeba Ba Aqeel, Pallawi Torka, Kira MacDougall, Azra Borogovac, Sridevi Rajeeve, Suchitra Sundaram, Kalub Fedak, Dipenkumar Modi, Elizabeth Travers, Sabarish Ayyappan, Nitin Chilakamarri, Elizabeth A Brem, Deborah M. Stephens, Boyu Hu, Lindsey A. Fitzgerald, Harsh Shah
Publikováno v:
Blood. 140:9390-9392
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d9183e175d61383087cc39964b248cd2
https://doi.org/10.1182/blood-2022-159001
https://doi.org/10.1182/blood-2022-159001
Autor:
Thilagavathi Ramamoorthy, Vaitheeswaran Kulothungan, Krishnan Sathishkumar, Nifty Tomy, Rohith Mohan, Sheeba Balan, Prashant Mathur
Publikováno v:
Reproductive Health, Vol 21, Iss 1, Pp 1-11 (2024)
Abstract Background Cervical cancer is ranked as the second most common cancer in India. This study aims to assess the cervical cancer burden at the national and subnational level in India, projecting it for the year 2025 in terms of years of life lo
Externí odkaz:
https://doaj.org/article/9ce8c613ed984bb5af8c46c8ea027015